跳至主要内容
临床试验/CTRI/2024/06/069491
CTRI/2024/06/069491招募中3 期

To study the efficacy and safety of Baclofen versus Baclofen and Naltrexone as Anticraving agents in patients of Alcohol Dependence with Alcoholic Liver Disease - NI

Rahul0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Aged 18 to 60 years
  • 2. Alcohol Dependence according to the DSM-5-TR
  • 3.JELLINEK’s alcoholic type gamma, delta and epsilon e type
  • 4.Adequate cognition and language skills to give valid consent and to complete research interviews
  • 5.Written informed consent
  • 6. Written informed consent for naltrexone, if applicable

排除标准

  • 1.Active major psychiatric disorder except alcohol dependence
  • 2.Pregnancy or lactating women
  • 3.Dependence on other substances except alcohol and nicotine
  • 4. Opioid abuse, opioid dependence or opioid agonist treatment, or likely need for opioid treatment
  • 5. Any evidence of alcoholic cirrhosis or advanced fibrosis, either clinically or through relevant investigations including fibroscan
  • 6.Lack of stable housing or contact phone number
  • 7.Previous hypersensitivity to baclofen or naltrexone
  • 8.Any pharmacotherapy related to alcohol dependence or ALD before enrolment
  • 9.Contra-indications for baclofen treatment were uncontrolled epilepsy, patent hepatic encephalopathy, and renal failure
  • 10. Contra-indication for naltrexone – Acute/ Fulminant liver failure

研究者

发起方
Rahul

相似试验

尚未招募
4 期
A study to compare whether oral baclofen or oral tizanidine is better in patients presenting with tightness of the upper limb after stroke.
CTRI/2024/03/064651Jalpaiguri Government Medical College and Hospital
进行中(未招募)
不适用
Efficacy evaluation of oral baclofen treatment versus intrathecal baclofen in children with dystonic cerebral palsy - Oral/intrathecal therapy in children with dystoniaDystonic or spastic dystonic cerebral palsyMedDRA version: 9.1Level: SOCClassification code 10029205MedDRA version: 9.1Level: PTClassification code 10008129MedDRA version: 9.1Level: LLTClassification code 10021740
EUCTR2008-000833-23-ITAZIENDA OSPEDALIERA ISTITUTI CLINICI DI PERFEZIONAMENTO DI MILANO
尚未招募
3 期
A pilot investigation of the effects of Baclofen on a quantitative electroencephalographic predictor of relapse to alcohol dependence.Alcohol Use DisorderMental Health - Other mental health disorders
ACTRN12613000372785Royal Adelaide Hospital20
进行中(未招募)
不适用
A placebo controlled trial with Baclofen for the treatment of GERD patients with incomplete PPI responseGastroesophageal reflux disease
EUCTR2009-017351-96-BEZleuven
进行中(未招募)
1 期
Study investigating the effect of baclofen in patients with postprandial regurgitation or belchingRumination syndrome and supragastric belchingMedDRA version: 14.0Level: LLTClassification code 10039292Term: Rumination disorderSystem Organ Class: 10037175 - Psychiatric disordersMedDRA version: 14.0Level: LLTClassification code 10004222Term: BelchingSystem Organ Class: 10017947 - Gastrointestinal disorders
EUCTR2011-002745-35-BEZLeuven20
To examine how well Baclofen and Naltrexone work as... | 临床试验